Hepatitis C Virus E2 Protein Ectodomain Is Essential for Assembly of Infectious Virions by Bianchi, Alessia et al.
SAGE-Hindawi Access to Research
International Journal of Hepatology
Volume 2011, Article ID 968161, 15 pages
doi:10.4061/2011/968161
Research Article
Hepatitis C Virus E2 Protein Ectodomain Is Essential for
Assembly of Infectious Virions
AlessiaBianchi,1 Stefania Crotta,1,2 MichelaBrazzoli,1 Steven K. H. Foung,3
andMarcello Merola1,4
1Department of Molecular Immunology, Novartis Vaccines and Diagnostic, Via Fiorentina 1, 53100 Siena, Italy
2Division of Immunoregulation, National Institute of Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK
3Department of Pathology, Stanford University, Stanford, CA 94305, USA
4Department of Structural and Functional Biology, University of Naples “Federico II” at MSA, 80132 Naples, Italy
Correspondence should be addressed to Marcello Merola, marcello.merola@novartis.com
Received 14 July 2010; Accepted 5 September 2010
Academic Editor: Claus Hellerbrand
Copyright © 2011 Alessia Bianchi et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The Hepatitis C virus E1 and E2 envelope proteins are the major players in all events required for virus entry into target cells. In
addition, the recently developed HCV cell culture system has indicated that E1E2 heterodimer formation is a prerequisite for viral
particle production. In this paper, we explored a new genetic approach to construct intergenotypic 2a/1b chimeras, maintaining
the structural region of the infectious strain JFH1 and substituting the soluble portion of E1 and/or E2 proteins. This strategy
provides useful information on the role of the surface-exposed domain of the envelope proteins in virus morphogenesis and
allows comparative analysis of diﬀerent HCV genotypes. We found that substituting the E2 protein ectodomain region abolishes
the production of chimeric infectious particles. Our data indicate that the soluble part of the E2 protein is involved in a genotype-
speciﬁc interplay with remaining viral proteins that aﬀect the HCV assembly process.
1.Introduction
Hepatitis C virus (HCV) is a positive-strand RNA virus that
belongs to the Flaviviridae family. Its genome of 9.6Kb is
composed of a 5  nontranslated region (NTR), a single ORF
encoding 10 single products and a 3  NTR [1]. Individual
proteinsaregeneratedviaco-andposttranslationalcleavages
mediated by both cellular and viral proteases. The core
structural proteins, E1 and E2, reside in the N-terminal
region of the polyprotein precursor. They are linked to the
replicase proteins NS3–NS5B via p7 and NS2, whose role,
even if not completely deﬁned, was recently established as
crucial in the assembly/release of nascent HCV particles [2–
4]. The poor replication of HCV in cell culture systems has
slowed down progress in viral life cycle studies; however,
this problem has been partially overcome by the discovery
of the infectious properties of the GT2a isolate JFH1
[5].
Relatively eﬃcient production of infectious HCV in cell
culture (HCVcc) was initially restricted to genotype 2a,
either as the authentic JFH1 isolate or as the intragenotypic
Jc1 chimera. Several eﬀorts have been made to extend
the HCVcc system by the construction of intergenotypic
chimeras. The availability of a spectrum of chimeric HCV
genomes diﬀering in their structural region is required
for comparative analyses of processes that are governed by
such proteins and for the screening of antiviral compounds
blocking the early steps of infection that ideally target all
HCV genotypes. Intergenotypic chimeras reported so far
consist of the 3 -half of the JFH1 genome and the 5  moiety,
including the whole or part of NS2, taken from a diﬀerent
genotype (GTs 1–7) [6]. This strategy was successful in
the case of intragenotypic chimera, but it did not allow
eﬃcient production of intergenotypic chimeric particles,
which suggests that determinants within the structural
proteins govern kinetics and eﬃciency of virus assembly
and release. Indeed, as deduced from the reported mapping
studies, virus release is most eﬃcient when the JFH1
substituted portion comprises the whole NS2, or part of it,
suggesting that genetic interactions between this protein and
upstream sequences are required for production of nascent
viral particles [7].2 International Journal of Hepatology
Together with the capsid protein, the main components
of HCV virion are the envelope proteins E1 and E2,
whose roles have been studied using heterologous expression
systems and replicon models. Overall, the data obtained
indicates that the E1 and E2 glycoproteins interact through
their transmembrane domain to form noncovalent het-
erodimers that represent the putative viral spike [8]. While
the transmembrane (TM) anchor region of both E1 and E2
is involved in ER retention and E1E2 association [9], the
soluble part plays major roles in the glycoprotein folding
process,invirusentry,andinmodulatingimmuneresponses
[10, 11]. In addition, the more recently developed HCVcc
system has suggested that E1E2 heterodimer formation is
a prerequisite for viral particle production. Indeed, the
abolishment of infectious virus production following trans-
fection of the defective JFH1/ΔE1E2 genome has shown that
the absence of envelope proteins results in a general block of
virionmorphogenesisandinﬂuencestheoverallinfectivityof
secreted particles, as cells transfected with JFH1/ΔE1E2 RNA
showed a dramatic reduction of core release [5, 7].
In the present study, we sought to investigate, in the
context of an infectious cycle, new potential functions of
E1 and E2 envelope proteins in the production of nascent
virions. We designed a new strategy to construct two
2a/1b intergenotypic chimeras, in which only the sequences
encodingfortheE1and/orE2glycoproteinectodomainwere
swapped from JFH1 to the Con1 strain (genotype 1b). Our
rationale was that by leaving the TM domain of the 2a strain,
correct interactions with other scaﬀold proteins required for
particle assembly would be maintained. At the same time,
the region carrying the HCV epitopes would appear as a
component of the 1b strain, allowing a comparative analysis
of the impact of the E1 and E2 surface-exposed domains on
virus morphogenesis.
The ﬁrst chimera we generated contained the ectodo-
main portion of both E1 and E2 of genotype 1b (JFH1/
Con1E1E2). This construct was able to replicate in trans-
fected cells, but it did not allow the production of infec-
tious chimeric particles. The same results were found for
the second chimera, JFH1/Con1E2, in which only the E2
ectodomain was swapped from genotype 2a to genotype
1b. This evidence led us to focus our attention on the
second chimera in order to better deﬁne the role of the
envelope protein E2 on nascent virion production. Since
in the JFH1/Con1E2 construct E1 and E2 have a diﬀerent
genotypic origin, we ﬁrst analyzed whether glycoproteins
from genotype 2a and 1b could correctly interact allowing
heterodimer formation. Next, confocal microscopy analysis,
transcomplementation experiments and analysis of infec-
tious particles within transfected cells led us to conclude
that the substitution of the E2 ectodomain leads to an
abortive particle assembly process. The causes of this genetic
incompatibility were explored and are discussed.
2.MaterialandMethods
2.1. Cell Lines. A l lc e l ll i n e sw e r eg r o w ni nD u l b e c c o ’ s
modiﬁed Eagle’s medium (DMEM, Gibco) supplemented
with10%fetalbovineserum(FBS,Hyclone),antibiotics,and
2mM l-glutamine. S6.1 cells, a subclone of Huh 7.5 cells
that has cleared the replicon [12] and na¨ ıve Huh7 cells were
used for HCVcc production and HCV infection, respectively.
S6.1/E1E2:2a and S6.1/E1E2:1b packaging cell lines that
stablyexpressHCVE1andE2glycoproteinsgenotype2aand
genotype 1b, respectively, were kindly provided by S. Crotta
and M. Brazzoli.
2.2. Plasmid Construction. The plasmids pUC.JFH1, con-
taining the full-length JFH1 genome (GenBank accession
number AB047639); pUC.JFH1ΔE1E2, where the entire
E1-E2 coding region has been deleted, and the full-
length replicon I389neo/core-30/5.1, encoding for genotype
1b replicon, have been described [13, 14]. The plasmid
pUC.JFHCon1E1E2 encodes the full length JFH1 genome
with the exception of the E1 and E2 ectodomain regions,
both deriving from the analogous portion taken from
the GT1b-Con1 strain. To design the Con1E1E2 chimeric
construct, a PCR-based strategy was adopted to substitute in
theJFH1sequencetheregioncorrespondingtotheE1andE2
protein ectodomain, from aa 192 to aa 329 and from aa 384
to aa 683 for E1 and E2, respectively. Similarly, the plasmid
pUC.JFHCon1E2 encodes the full-length JFH1 genome with
theregionfromaa384toaa683(E2ectodomain)substituted
with the analogous region from the GT1b Con1 strain (See
Figure S2 in Supplementary Material available online at
doi:10.1155/2010/968161).
2.3. In Vitro Transcription RNA and Electroporation. In vitro
transcripts of the individual constructs were synthesized as
described [15]. For electroporation of HCV RNA into S6.1
cells, single-cell suspensions were prepared by trypsinization
of monolayers and subsequent resuspension in complete
DMEM. S6.1 cells were washed with phosphate buﬀered
saline (PBS), counted, and resuspended at 6 × 106 cells per
ml.FiveμgofinvitrotranscribedRNAwasmixedwith400μl
of cell suspension by pipetting and then electroporated with
a Gene Pulser system (Bio-Rad, Munich, Germany) in a
cuvette with a gap width of 0.4cm (Biorad) at 975μFa n d
270V.Cellswereimmediatelytransferredto6mlofcomplete
DMEM, and 150μl of the cell suspension was seeded per well
in a 48-well plate. The cells were trypsinized and passaged
every 3-4 days for 8 passages as previously described [16].
2.4. Immunoﬂuorescence Staining and Virus Titration. Trans-
fected and infected S6.1 cells were ﬁxed with cold 4%
paraformaldehyde for immunoﬂuorescence (IF) analysis and
then stained with mouse anti-HCV core antibody 3G1-1
(Chironcorporation,USA),orwiththeanti-E1E2polyclonal
chimpanzeeantiserumCh-L559 (ChironCorporation, USA)
followed by Alexa Fluor 568-conjiugate goat antimouse
(Molecular Probes), or Alexa Fluor 488-conjiugate goat
antihuman (Molecular Probes). Replication positive cells
were determined by core detection under a ﬂuorescence
microscope (Zeiss, Observer.A1). The infectivity titer was
d e t e r m i n e do nH u h7n a ¨ ıve cells by end-point dilution and
immunoﬂuorescencestaining.Typically,15μlofsupernatantInternational Journal of Hepatology 3
or cell lysate was serially diluted 10-fold in DMEM 10% FCS
according to the Spearman and Kaerber ﬁt. Cells were seeded
in 96-well plates at a density of 1 × 104 cells per well 24h
prior to inoculation with 100μl of the diluted supernatant
or cell lysate (at least eight wells were used per dilution).
Cells were ﬁxed 72 hours postinfection, permeabilized, and
core-stained as described above. Virus titer was expressed
in particles forming units per ml (pfu/ml) enumerating the
positive cells by use of a ﬂuorescent microscope.
2.5. Cell Labeling and Pulse-Chase Experiment. Subconﬂuent
35 mm diameter dishes of S6.1/JFH1 and S6.1/JFHCon1E2
transfected cells (or not transfected as negative control) were
starved for 1 hour at 37
◦C in cysteine- and methionine-
free medium. Cells were pulse-labeled in the presence
of methionine- and cysteine-free medium supplemented
with 350μCiml−1 of [35S]-labeled methionine and cysteine
(ProMix, Amersham Pharmacia Biotech) for 20min at 37
◦C.
The pulse period was stopped by washing cells twice with
PBS. For metabolic labeling, the starving step was skipped
and cells were incubated for 6 hours to overnight in the pres-
ence of 50μCiml−1 of [35S]-labeled methionine and cysteine
(ProMix). Chase period was initiated by adding complete
DMEM supplemented with 2.5mM unlabeled methionine
and cysteine, and incubating cells for diﬀerent chase times at
37
◦C. For dithiothreitol (DTT) resistance experiments, the
regular chase was followed by 5min incubation at 37
◦Ci n
presence of 5mM DTT. After chase time, cells were placed
on ice, then the medium was removed and replaced with ice-
cold PBS containing 20mM N-ethylmalamide (NEM). This
alkylating agent blocks free sulphydrilic groups and prevents
further oxidation of the cysteines [17]. After 5min of PBS-
NEM incubation, cells were lysed in 900μll y s e sb u ﬀer,
containing 1% Triton X-100 in HEPES-buﬀeredsaline (HBS,
pH 7.4) including a protease inhibitors cocktail (Complete,
EDTA free, Roche), 1mM phenylmethylsulfonyl ﬂuoride
(PMSF), and 1mM NEM. After 30min of incubation at
4◦C under agitation, total lysates were centrifuged 20min at
13,000×g to pellet nuclei and cellular debris. Postnuclear
supernatants (PNSs) were used for immunoprecipitation
with speciﬁc anti-E2 antibodies.
2.6. Antibodies, Immunoprecipitation and SDS-PAGE. The
two speciﬁc anti-HCV E2 antibodies used in this study
are the human monoclonal conformational anti-E2 CBH-
2 and CBH-5. They are two of a panel of nine conforma-
tion sensitive antibodies generated from peripheral B-cells
of an asymptomatic HCV-infected individual [18]. These
antibodies do not recognize denatured E2, inhibit binding of
E2 to the putative receptor CD81, and speciﬁcally recognize
properly folded E2 (GT2a and 1b, resp., for CBH-2 and
CBH-5). PNSs were precleared on protein G coupled to
Sepharose Fast Flow (Amersham Pharmacia Biotech) for 1h
at 4◦C and were subsequently immunoprecipitated with 1μg
of CBH-2 or CBH-5 at 4◦C overnight in presence of 10μl
Dynabeads Protein G (Dynal Biotech ASA). The radioactive
counts of the TCA-precipitated fraction were determined
on 2μl of each precleared lysate. Equivalent amounts of
total labeled proteins were used for CBH-2 or CBH-5
anti-E2 immunoprecipitations. Theimmunocomplexes were
collected with the proper magnetic device, washed three
times with lysis buﬀer, and solubilized at 95
◦C for 5min in
20μl of SDS loading buﬀer and separated on SDS-PAGE,
followed by autoradiography. For SDS-PAGE in reducing
conditions, DTT 100mM ﬁnal was added to the samples.
2.7. Endoglycosidase H Treatment. Endoglycosidase H
(EndoH) cleaves ER type N-linked high mannose sugar
chains between the two N-acetylglucosamine residues, thus
eliminating most of the contribution of the glycan to the
apparent molecular weight in SDS electrophoresis [19].
Immunoprecipitated proteins recovered from beads were
incubated with 50mU endoH in 250mM sodium acetate pH
5.5, in a ﬁnal volume of 0.25ml. The reaction was performed
for 6 hours at 37
◦Ci np r e s e n c eo f1 m MP M S F .D i g e s t e d
proteins were added to loading buﬀer with (reducing)
or without (nonreducing) 100mM DTT for SDS-PAGE
analysis.
2.8. Confocal Analysis. S6.1/JFH1 and S6.1/JFHCon1E2 cells
(or S6.1 not transfected cells as negative control) were
plated on 30mm coverslips in 24-well plates at a density
of 5 × 104 cells per well. One day after seeding, cells
were ﬁxed in 4% formaldehyde, permeabilized with 0.1%
Triton X-100 in PBS, pretreated with blocking solution
(0.5% bovine serum albumin in PBS) and incubated at
room temperature with the primary antibodies diluted in
blocking solution. After three washes in PBS, AlexaFluor-
conjugated secondary antibodies were added to the cells.
Lipid droplets were stained in paraformaldehyde-ﬁxed cells
by brieﬂy rinsing coverslips in 60% propan-2-ol followed by
incubationwith0.5ml60%propan-2-olcontainingoilredO
(ﬁnal concentration approximately 0.6%) for 1.5 to 2min at
room temperature. Coverslips were brieﬂy rinsed with 60%
propan-2-ol and washed with PBS and H2O. The oil red
O staining solution was prepared from a saturated stock of
approximately 1% oil red O (Sigma) dissolved in propan-2-
ol. Before staining, the stock was diluted with H2O and then
ﬁltered [20]. Coverslips were mounted in aqueous mounting
medium Vectashield. Confocal microscopy was performed
with a Bio-Rad 2100 Confocal Microscope using 60x oil or
100x oil objectives. Image analysis was performed using the
standard operating software provided with the microscope.
2.9. Cell Lysate Preparation, Sedimentation Equilibrium
Gradient, and Western Blot Analysis. S6.1/JFH1 and
S6.1/JFHCon1E2 cells were washed once with PBS and
incubated with trypsin-EDTA for 2min at 37
◦C. Cells
were resuspended in PBS and collected by centrifugation
at 1,500rpm for 3min. The cell pellet was resuspended in
DMEM-10% FCS, and cells were lysed by four freeze-thaw
cycles in liquid nitrogen and a 37
◦C water bath, respectively.
Cell debris was pelleted by centrifugation for 5min at
4,000rpm. The supernatant was collected and overlaid onto
a discontinuous sucrose gradient. Gradients were formed by
equal-volume (750μl) steps of 20%, 30%, 40%, 50%, and4 International Journal of Hepatology
60% sucrose solutions in TNE buﬀer (10mM Tris-HCl, pH
8, 150mM NaCl, 2mM EDTA). 250μl of each supernatant
were overlaid on the gradients, and an equilibrium was
reached by ultracentrifugation for 16 hours at 36,000rpm
(135,000×g) in an SW60Ti rotor at 4◦Ci naB e c k m a nL 8 -
80M preparative ultracentrifuge. After ultracentrifugation,
gradient fractions were collected from the top and titrated
for virus infectivity as previously described. The density of
the fractions was determined by measuring the refractive
index of 10-μla l i q u o t so fe a c hs a m p l e .
For immunoblot analysis, samples were added to SDS-
loading buﬀer, heated for 5min at 95
◦C ,a n dl o a d e do n t o
a 10% polyacrylamide-SDS gel. Primary antibodies used
were core-speciﬁc mouse monoclonal antibody (3G1-1) at a
1:500 concentration, polyclonal antiserum Ch-L559 against
E1 and E2 proteins at a 1:1000 dilution, and the mouse
monoclonal MMM33 anti-NS3 (Novocastra Lab. Ltd. anti-
NS3 antibody) at a 1:200 dilution. Bound antibodies were
detected after a washing step with the ECL plus Western
blotting detection system (GE Healthcare).
3. Results
3.1.ConstructionandCharacterizationofIntergenotypic2a/1b
HCV Genomes. E1 and E2 envelope proteins associate to
form noncovalent heterodimers that have been indicated as
the major players for virus entry into target cells [10]. This
dimerization is also involved in processes that lead to the
production of nascent virions, since it has been shown that
deletion of the E1 and E2 coding region blocks infectious
particle morphogenesis [5]. In this study, we sought to
further investigate the production of nascent virions by
using a new strategy to design two 2a/1b intergenotypic
chimeras. To verify whether E1 and E2 proteins are involved
in the assembly process, a system in which modiﬁcations
of one or both envelope proteins could be introduced
without aﬀecting viral RNA replication or heterodimer
association was required. To achieve this goal, we replaced
the region corresponding to the E1 and/or E2 ectodomain
in the assembly-competent JFH1 genome with the same
portions taken from the GT1b isolate Con1 (Figure 1(a)).
We speculated that since heterodimerization determinants
have been ascribed to the TM regions of both glycoproteins,
the swapping of the “soluble” domains should not aﬀect
the formation of the complex. Furthermore, leaving the
TM domain of the 2a strain intact, we allowed interactions
to be maintained between the envelope proteins and other
proteins of the scaﬀold that might be required for particle
assembly. On the other hand, by generating a viral genome
carryingthesurface-exposedportionofE1and/orE2derived
from a heterologous strain (GT 1b), our system allowed
a comparative analysis of the impact of the ectodomain
moieties on virion morphogenesis.
For E1/E2 swapping, we targeted the soluble domains
excluding the “membranotropic” regions. To achieve this,
we submitted the C-terminus regions of both glycoproteins
to secondary structure prediction analysis based on two
algorithmics, j-pred and phy-pred. We found that for
both proteins, the region with hydrophobic characteristic
is wider than that reported in the literature. In particular,
in the predicted structures the membrane spanning region
starts at position 330 instead of 353 for E1 and initiates
at residue 683 instead of 718 for E2 (see Figure S1 in
Supplementary Material). Although the validation of this
analysis was beyond the scope of this work, we based our
PCR strategy to substitute the E1 and/or E2 ectodomain on
this novel conﬁguration, thus obtaining the JFH1/Con1E1E2
and JFH1/Con1E2 constructs, as described in Figure S2 in
Supplementary Material.
To characterize the engineered HCV-JFH1 genomes,
S6.1 cells were transfected with JFH1/Con1E1E2 and
JFH1/Con1E2 chimeric RNAs in parallel with the wild type
genome, which was used as a control in all experiments in
this study. Cell culture media were harvested from 72 hours
after transfection, and each cell type was checked for the
presenceoftheviralcorebyimmunoﬂuorescencestaining.In
parallel, cell lysates were submitted to immunoblot analysis.
The positive cells showed core-speciﬁc cytoplasmic staining
patterns as previously described [21]. In all samples, replica-
tionappearedtobeeﬃcientinabout80%–90%ofcells,indi-
cating that the substitution of the ectodomain region does
not aﬀect HCV replication (Figure 1(b)). The immunoblot
obtained on cell lysates using the anticore antibody revealed
a single band of approximatively 20KDa consistent with
the molecular weight of the protein (Figure 1(b),b o t t o m
panel). The core signal is comparable in all samples, further
conﬁrming that there are no diﬀerences in terms of repli-
cation ability between wild-type and chimeric constructs.
Next, in order to verify the release of infectious particles
by S6.1 transfected cells, cell supernatants were collected at
diﬀerent time points, from 3 to 30 days posttransfection,
and tested for infectivity by inoculation onto Huh7 na¨ ıve
cells. After 72 hours, infected cells were ﬁxed, permeabilized,
and examined for foci of cells expressing HCV core protein
by using indirect immunoﬂuorescence. A proper titration
was possible solely for the S6.1/JFH1 cells since none of
the chimeric constructs allowed the production of infectious
particles (data not show).
As the ability of the viral RNA to replicate was not
aﬀected by the glycoprotein exchange, the ectodomain
swapping most likely aﬀects one or more of the steps
downstream RNA replication. Based on this consideration,
we performed a series of experiments to evaluate which
process is inﬂuenced by the substitution of the E1 and
E2 ectodomain-coding region in the JFH1 scaﬀold. It is
reported that the E1-core protein interaction is important
for a proper viral particle assembly process, as E1 associates
with the core protein through a cytoplasmic loop containing
ﬁve amino acids (312–315) [22]. To exclude the possibility
that the observed lack of infectious particle production by
our chimera was simply due to the inability of Con1-E1
to interact with the capsid protein, we decided to focus
our attention on the JFH/Con1E2 chimera in which the
original JFH1-E1 sequence is maintained. Regarding the E2
protein, it is worth noting that its transmembrane region is
reported to play a key role in the coordinated assembly and
reorganization of the E1E2 heterodimer [23]. However, in
our chimeric JFH1/Con1E2 construct, the E2 TM region isInternational Journal of Hepatology 5
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Figure 1: Chimeric JFH1/Con1E1E2 and JFH1/Con1E2 constructs are replication-competent. Schematic representation of the constructs
used in this study (a). JFH1-derived 5  and 3  nontranslated regions are drawn as thick black lines and JFH1 proteins are depicted as open
boxes. JFH1/Con1E1E2 and JFH1/Con1E2 comprise chimeric HCV E1 and E2 proteins consisting of Con1 (black boxes) fused with JFH1
at the indicated positions. (b) Replication of JFH1 and given mutants. S6.1 cells were ﬁxed 72hrs posttransfection, permeabilized, and
incubated with mouse anticore mAb (3G1-1). Cells were then stained with antimouse-AF-568 secondary antibody (red) and replication-
positivecellswerevisualized bycore-speciﬁcimmunoﬂuorescence. Western blotanalysisofPNSsfromJFH1,Con1/E1E2,andJFH1/Con1E2
transfected cells and from not transfected cells (NT) is also reported on the bottom. The band of ∼20Kda resulted from SDS-PAGE
correspond to core protein.
derived from the genotype 2a, as well as the E1 protein. In
this way, the ability of the chimeric E2 to dimerize with E1
JFH1-derived protein should be maintained.
3.2. Folding and Maturation Process of Chimeric E1-2a/E2-1b
Heterodimers. The E1 and E2 proteins are targeted to the
ER by a signal sequence and are cotranslationally separated
from each other by host signal peptidase cleavage. In the
ER, they acquire several N-linked oligosaccharide chains
and assemble into noncovalently bound E1E2 heterodimers
that represent the functional units of the HCV spike
[24]. To analyze the formation of the heterodimer in our
system, we tested several anti-E2 conformational mAbs in
immunoprecipitation of metabolic labeled S6.1/JFH1 wild
type (wt) and S6.1/JFHCon1E2 cell lysates, and checked
for the presence of coimmunoprecipitated E1. We found
that E2 was immunoprecipitated by the conformational
monoclonal antibodies CBH-2 and CBH-5 for the JFH1-
or Con1-derived proteins, respectively (Figure 2(a)). The
simpleobservationthatCBH-5recognizedE2fromgenotype
1b and coimmunoprecipitates E1 from genotype 2a attested
that glycoproteins from diﬀerent genotypes are able to form
heterodimers.
To better deﬁne the behaviour of newly synthesized E1
and E2, S6.1/JFH1 and S6.1/JFHCon1E2 cells were pulse-
labeled for 20min and chased for diﬀerent time periods.
Figure 2(a) shows the oxidative status of immunoprecip-
itated E2 and coimmunoprecipitated E1 from 30min to
6 hours after synthesis. Concerning the wild type species
(Figure 2(a), left panel), the formation and recognition
of the conformational epitope on E2 is weakly revealed
30min after synthesis, becoming more evident after 2 hours.6 International Journal of Hepatology
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Figure 2: Oxidation kinetics and DTT-resistance analysis of HCV proteins E1 and E2. (a) S6.1 cells transfected with JFH1 or JFH1/Con1E2
RNA were pulse labeled with [35S] methionine and cysteine for 20min and chased for diﬀerent time periods, from 30min to 6hrs. PNSs
were immunoprecipitated with a conformational monoclonal anti-E2 antibody (CBH-2 and CBH-5 for genotypes 2a and 1b, resp.) and
analyzed on SDS-PAGE. Chase periods are reported above the lanes. Samples were analyzed on 10% SDS-PAGE under nonreducing (n.red)
and reducing (red) conditions (DTT 200mM). (b) S6.1 cells transfected with JFH1 or JFH1/Con1E2 RNA were pulse labeled and chased
for the indicated time periods, in duplicate. One of the dishes in each pair was chased for an additional 5min in the presence of 5mM
DTT (+) in the culture media before proceeding with lysis. PNSs were immunoprecipitated with CBH2 or CBH5 for genotype 2a and 1b E2
proteins, respectively. Upper panel, E2 protein. Lower panel, E1 protein. The samples were analyzed on 10% SDS PAGE under reducing and
nonreducing conditions. Symbols refer to diﬀerent form of E1 and E2: ox for oxidized; red for reduced; pr for protein precursor; NT for not
transfected. Position on gel of prestained Molecular Weight marker (Amersham) is reported on the right side.
Immunoprecipitation of E2 with the conformational Ab
always carries down E1, indicating that the formation of the
conformational epitope on E2 is contemporary, or follows,
the formation of the E1E2 heterodimers. We observed a
similar pattern for both the wt and the chimeric E1E2
heterodimers (Figure 2(a), right panel), indicating that the
Con1-derived E2 portion interacts with the E1 glycoprotein
encoded by JFH1. In both gels, a slower migrating band
of about 100Kda is also seen, which most likely represents
the unprocessed E1E2 precursor, still associated to p7 as
described in other reports [25, 26] .T h eh a l fl i f eo ft h i s
species, that inversely correlate with the appearance of
mature E2, is the most remarkable diﬀerence between the
wild type and the chimeric samples. In fact, by comparing
the two panels of Figure 2(a),i ti se v i d e n tt h a ta f t e r4h r so f
chase the chimeric precursor is still present while the wild
type one has completely disappeared. The diﬀerent kinetics
of the E1E2p7 precursor processing and the parallel slower
appearance of the chimeric E1E2 heterodimer suggests a
more complex process of association between E1 and E2
proteins that are derived from diﬀerent genotypes.
TofurtherassesstheoxidationstatusofE2inthediﬀerent
steps of wt and chimeric heterodimer folding kinetics, we
performed a DTT-sensitivity assay on both samples. In
completely folded proteins, disulﬁde bonds are protected
from reduction by exogenously added reducing agents such
as DTT. Conversely, in incompletely folded species, the
S - Sb o n d sa r ea c c e s s i b l ea n dt h et r e a t m e n tw i l lr e s t o r e
the reduced state of the cysteines [25, 27]. To perform
this experiment each chase-time was done in duplicate,
with one of the two samples treated with DTT for 5min
before the end of the chase-period. Normalized samples
were immunoprecipitated and HCV glycoproteins separated
by SDS-PAGE (Figure 2(b)). Since we used conformational
anti-E2antibodiesthatrecognizeDTT-sensitiveepitopes,the
un-oxidized form of E2 will not be immunoprecipitated in
presence of the reducing agent and, therefore, will not be
present on the gel. The relative amount of DTT-resistant
native species can, therefore, be evaluated by comparing the
intensity of the E2 bands in a DTT treated sample versus
the untreated sample. Figure 2(b) shows that the behaviour
of E2 is similar when derived from JFH1 or Con1, showing
a time-dependent increase of DTT-resistance that is almost
complete at the 6 hour chase-point. Since the achievement of
a DTT resistant conformation is a strong indication that the
protein is in its native state, this data supports the previousInternational Journal of Hepatology 7
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Figure 3: Oxidation kinetics and glycosylation processing of E1E2 heterodimer. (a) S6.1 cells transfected with JFH1 or JFH1/Con1E2 RNA
were pulse labeled with [35S] methionine and cysteine for 20min and chased for diﬀerent time periods, from 6hrs to 48hrs. PNSs were
immunoprecipitated with a conformational monoclonal anti-E2 antibody (CBH2 or CBH5, resp., for genotype 2a and 1b) and analyzed
on SDS-PAGE. Chase periods are reported above the lanes. Samples were analyzed on 10% SDS-PAGE under nonreducing and reducing
conditions (DTT 200mM). (b) Transfected cells were metabolically labeled for 6hrs in presence of [35S] Met and Cys. E1 and E2 proteins
wereimmunoprecipitatedfromthePNSwithCBH-2orCBH-5,respectively,forwtandchimericspecies,treated(+)ornot(−)withendoH
andanalyzed on10%SDS-PAGEundernonreducingconditions.NotethatCon1-derivedproteinsdisplayanhigherelectrophoreticmobility
than E1E2 proteins from JFH1 transfected cells. Symbol Δgly is for deglycosylated proteins.
conclusion that GT1b-E2 is able to complete its oxidative
foldingalsoinadiﬀerentgenotypiccontext,suchastheJFH1
genome.
However, the slower maturation of the chimeric protein
precursor led us to speculate that it could accumulate in
the ER-compartment where, if not correctly processed, it
could be targeted to the proteasomal pathway. We addressed
this question by extending the chase period to 48 hours
for both S6.1/JFH1 and S6.1/JFHCon1E2 cells (Figure 3(a)).
Although the Con1-derived E2 was cleared to a higher extent
than the wt, the diﬀerence was not dramatic and the absence
of smeared E1 and E2 bands was consistent with a successful
folding process. In addition, inhibitors of the proteasomal
degradation pathway such as Lactacystein and MG132 did
not inﬂuence the amount of E1 and E2 recovered at the later
chase-time (data not show). This provides further evidence
against a proteasomal degradation mechanism and excludes
the possibility that E1 and E2 glycoproteins are degraded due
to slower heterodimerization and, therefore, not available for
incorporation into nascent chimeric particles.
Comparative analysis of the glycosylation status of
both wild type and chimeric heterodimers also ruled out
diﬀerences in posttranslational modiﬁcation between the
two samples (Figure 3(b)). A peculiar characteristic of HCV
envelope glycoproteins is the high extent of N-linked glycans
atpositionsstronglyconservedalongthediﬀerentgenotypes,
and the absence of post-ER types of modiﬁcation [8].
MetabolicallylabeledS6.1/JFH1andS6.1/Con1E2celllysates
were immunoprecipitated, and the proteins recovered from
the beads were incubated in the presence or absence of the
EndoHenzyme,whichisacommontreatmenttoanalyzethe
glycosylation status of proteins [19]. The digested proteins
were then analyzed by SDS-PAGE in reducing conditions.
As shown in Figure 3(b), in both samples the E1 and E2
proteins migrate considerably faster after Endo H digestion,
consistent with a complete deglycosylation. Upon Endo
H treatment, we could visualize a splitting of the band
corresponding to E2 protein. This is consistent with the
simultaneous presence of two species, the mature E2 and
the E2p7 precursor, which has already been described in
previous reports [25, 26]. Analysis of the glycans bound to
HCV envelope glycoprotein have indicated that only high-
mannose type oligosaccharides are associated with these
proteins, thus excluding that, as for the wild type, the
chimeric heterodimers have transited through the Golgi
compartment [28].8 International Journal of Hepatology
3.3. Subcellular Localization of Viral Structural and Nonstruc-
turalProteinsinS6.1/JFH1andS6.1/Con1E2TransfectedCells.
Folding analysis and deglycosylation studies support the idea
that the chimeric E1E2 undergoes correct maturation and
association processes leading to the formation of functional
heterodimers, crucial for the infection ability of the nascent
v i r a lp a r t i c l e s .A sac o n s e q u e n c e ,o u rn e x ta t t e m p tw a s
to clarify the subsequent step in the viral particle genera-
tion, namely, the assembly process. To date, there is little
understanding of the mechanism underlying the assembly
process of HCV in cultured cells. However, recent studies
have assessed the role of the cellular lipid droplets (LDs) as
potentialassemblysites.Inparticular,takingadvantageofthe
JFH1 culture model, it was demonstrated that the HCV core
and NS5a perfectly colocalize with LDs, showing a ring-like
pattern that corresponds to the surface of LDs [29].
In this study, we investigate the subcellular localization
of HCV E1 and E2 envelope proteins in order to evaluate
potentialdiﬀerencesintheviralproteindistributionbetween
wild type and chimeric transfected cells that might be the
cause of a deﬁcient assembly process. Transfected cells were
grown on glass coverslips, ﬁxed with paraformaldehyde and
processed for indirect immunoﬂuorescence with speciﬁc
antibodies againstE1E2, coreandNS5aproteins, andstained
withoilredOtospeciﬁcallymarklipiddroplets.Asshownin
Figure 4(a), E1E2 heterodimers are distributed in a compa-
rable way in both JFH1 and JHF1/Con1E2 transfected cells.
In particular, they show a pattern of speciﬁc ﬂuorescence
in a network of cytoplasmic membranes and at the nuclear
periphery. This is consistent with previous data obtained
by using the HCVcc system [21] and deﬁnitively conﬁrms
that E1/E2 proteins are retained in the ER compartment, as
already shown in other studies performed with diverse het-
erologous expression system [30, 31]. Concerning the capsid
protein, the staining in both S6.1/JFH1 and S6.1/Con1E2
cells reveals an organization in ring-like structure, already
reportedinthecontextofcellstransfectedwiththeinfectious
JFH1 genome [29, 32]. When lipid droplets are labeled with
oil red O the association between the core protein and LDs is
clear (see merge panels Figure 4(a)). Furthermore, in both
wt and chimeric species most of the core localizes on the
LDs surface (see zoomed panel Figure 4(a)), but the cellular
distribution of such complexes diﬀers in the two cell types.
More precisely, in S6.1 transfected with the JFH/Con1E2
genome,associatedLDs-coremostlyaccumulateintheapical
periphery of the cell. By contrast, in almost all cells trans-
fected with the wt genome, LDs-core coated do not cluster
but rather are distributed throughout the cytoplasm. To gain
more accurate information about the relative localization
of structural proteins, we explored the colocalization of the
E1E2heterodimerwithcoreandrevealedanadditionalslight
diﬀerence between the two cell types. In fact, while not
evident in S6.1/JFH1 cells, in a minor subset of S6.1/Con1E2
cells (roughly 20%), we detected a diﬀerent pattern of
E1E2 distribution locally concentrated in dot-like structures
(Figure 4(b), bottom panel). In these structures, E1E2 co-
localize with the core protein (see merge on the bottom
panel). It is worth noting that such structures, in which all
the viral components accumulate, are typical of the replicon
system, that was often used in HCV research, but that
cannot support the production of infectious particles [33].
We speculate that these pointed structures could represent
sites of storage of viral proteins that cannot be incorporated
into nascent virions, thus hindering release of the virus.
Indeed, a rapid assembly process should result in a rapid
liberation of HCV proteins from LDs and would not result
in an accumulation of structural proteins in the periphery of
the cell, as observed in S6.1/Con1E2 cells [32].
In addition to the core, it has recently been proposed
that NS5a plays a signiﬁcant role in the assembly of HCV
particles. In particular, it has been proposed that NS5a is
involved in the recruitment of the replication complex on
the LDs surface, an indispensable event to trigger particle
formation [34, 35]. As shown in Figure 5, in S6.1/JFH1 cells,
E1 and E2 and the nonstructural protein NS5a co-localize in
the membranous web, which is the hypothetical site of the
replication complex, conﬁrming that the replication and the
assembly factories might be located within the same region.
In S6.1/Con1E2 cells, NS5a localization appeared more spot-
like, with the optimal co-localization with E1E2 heterodimer
corresponding to the dot-like structures described above.
3.4. S6.1/Con1E2 Cells Do Not Contain Immature Infectious
Viral Particle. Confocal microscopy analyses suggest that
there is an inverse correlation between the eﬃciency of virus
production and LDs-core protein clustering within the cells.
To further investigate if these observations reﬂect a real
functional diﬀerence in terms of particle production, we
veriﬁed whether chimeric particles are correctly assembled
and then accumulated in S6.1/Con1E2 cells. Recent studies
reported the existence of infectious HCV particles within
hepatoma cells transfected with the JFH1 genome. In such
studies, it was demonstrated that the intracellular particles,
considered as immature viruses, exhibit a diﬀerent buoyant
density with respect to the particles secreted in the milieu,
but that they are already infectious when used to inoculate
Huh7 na¨ ıve cells [36, 37]. If intracellular immature virions
are formed by our chimeric proteins, then the defect could
be ascribed to the release step. On the contrary, in the case of
infectious particles which are not found within S6.1/Con1E2
cells,theconclusionshouldbethattheassemblyprocessitself
cannot proceed to maturation.
To release intracellular infectious particles, S6.1/JFH1
and S6.1/Con1E2 cells were lysed by four freeze-thaw cycles
andthePNSwereloadedontoadiscontinuoussucrosegradi-
ent (20% to 60% in TNE buﬀer). As reported in Figure 6(a),
in S6.1 cells transfected with the wild type genome, we were
able to detect cell-associated infectivity in fractions corre-
sponding to densities ranging from 1.15 to 1.21g/ml. This
data is in agreement with that reported in the literature and
it is consistent with the presence of intracellular infectious
particles. By contrast, none of the fractions collected from
S6.1/Con1E2celllysatesshowedanyinfectivity(Figure 6(b)).
The lack of infectious particles inside the cells transfected
with the chimeric genome conﬁrms the idea that the E2
ectodomain exchange aﬀects the assembly process rather
than the following release step. The Western blot analysisInternational Journal of Hepatology 9
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Figure 4: Intracellular distribution of HCV structural proteins. Transfected S6.1/JFH1 and S6.1/Con1E2 grown on coverslips were ﬁxed and
stained with the anti-E1/E2 chimpanzee antisera L559 (green) and the mouse monoclonal antibody 3GI-I (blue). Lipid droplets were stained
with oil red O. The merge images and the corresponding magniﬁcation are shown on the right. (a) Intracellular distribution of E1/E2, core
and lipid droplets. (b) Relative intracellular colocalization of E1/E2 and core proteins. For S6.1/Con1E2 cells, two diﬀerent populations are
showed in panel (b). Bars, 20μm.
of the density-separated species was pursued to check the
presence of the structural proteins (Core, E1, and E2) and
the nonstructural NS3 in each fraction, for both S6.1/JFH1
and S6.1/Con1E2 transfected cells. Comparing the pattern
of distribution of the viral structural proteins, we noted
an accumulation of core and E2 proteins at the bottom of
the gradient (fraction 9) in the case of S6.1/Con1E2 cell
lysate (Figure 6(b)) that was not observed in the wt sample
(Figure 6(a)). This evidence indicates that a consistent
portion of the capsid, as well as the E2 protein, is present
as high molecular weight complexes that sediment at high
concentrations of sucrose. These complexes likely represent
nonfunctional aggregates, probably composed mainly of
proteins (core and other viral and cellular proteins) and of
cellular membranous structures. Finally, the more diﬀuse
shape of the E1 and E2 bands in the chimeric sample is
consistent with the presence of heterogeneous species that
are most likely incorrectly folded forms of the two proteins10 International Journal of Hepatology
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Figure 5: Intracellular distribution of HCV structural and nonstructural proteins. Transfected S6.1/JFH1 and S6.1/Con1E2 grown on
coverslips were ﬁxed and double-stained with the anti-E1/E2 chimpanzee antisera L559 (red) and the anti-NS5 rabbit monoclonal antibody
(blue). The merge images and the corresponding magniﬁcation are shown on the right. Bars, 20μm.
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Figure 6: Sedimentation equilibrium analysis. Buoyant density proﬁle of S6.1/JFH1 (a) and S6.1/Con1E2 (b) cell lysates determined by
equilibrium ultracentrifugation in sucrose gradient is reported on the top panel. Fractions of the 20%–60% gradient were collected from the
top, and infectivity was determined by serial dilution and immunoﬂuorescence staining anticore protein. The infectivity (pfu/ml) is shown
as a bar chart. The density (g/ml) of each fraction is shown as a dotted line. Each sucrose fraction was processed by Western blot analysis
as reported below the corresponding chart. The mouse monoclonal MMM33 anti-NS3 was used to detect the HCV nonstructural protein
NS3, E1 and E2 proteins were revealed by the polyclonal Ch-L559 antisera and core protein was detected by the mouse monoclonal antibody
3G1-1.International Journal of Hepatology 11
(Figure 6(b)). This observation strongly indicates that the
E2 ectodomain swapping generates a remarkable amount of
misfolded glycoproteins whose permanence inside the cell
could in part explain the impairment of particle assembly. It
isworthnotingthatthesedead-endspecieswerenotrevealed
in immunoprecipitation (IP) using conformational anti-E2
antibodies but were recognized by an anti-E1/E2 antisera.
Indeed, diﬀerently from the monoclonal CBH-2 and CBH-
5 antibodies, the polyclonal Ch-L559 antisera recognized all
forms of E1 and E2 in Western blot analysis [38, 39].
3.5. The JFH1/Con1E2 Defective Genome Can Be Rescued
by the transcomplementation of the GT2a-E2 Ectodomain
Region. Overall, the data shown so far attest that the inter-
change of E2 ectodomain profoundly alters the eﬃciency of
viral assembly at early stages of particles formation. These
observations led us to suppose a genetic incompatibility
between the genotype 1b E2 protein and genotype 2a
structural proteins. We further investigated this possibility
by designing an experiment that takes advantage of the
“ﬂexibility” of the HCV RNA genome. In fact, the assem-
bly of HCV progeny viruses can be achieved providing
a nuclear constitutive expression of the entire structural
region, from core to NS2 protein, to a subgenomic replicon
[40, 41]. Therefore, considering our chimeric genome as
defective for some assembly functions, we sought to rescue
the production of infectious particles by providing the
lacking functions in trans. To carry out this experiment,
we used two diﬀerent S6.1 packaging cell lines that stably
express the HCV E1 and E2 envelope proteins, one from
genotype 2a and the other from genotype 1b, designed
S6.1/E1E2:2a and S6.1/E1E2:1b, respectively. We transfected
each cell line with the wt and chimeric JFH1/Con1E2 RNAs,
and we used the JFH1ΔE1E2 construct as a control for
the transcomplementation. Supernatants from transfected
S6.1/E1E2:2a and S6.1/E1E2:1b cells were collected from
day 3 to day 7 and each one was titrated by inoculating
Huh7 na¨ ıve cells. As expected, the JFH1 full-length genome
allows the production of infectious particles, conﬁrming
that both packaging cell lines support HCV replication,
assembly, and release (Figure 7). However, when comparing
the virus titers obtained from S6.1/E1E2:2a (Figure 7(a))
and S6.1/E1E2:1b cells (Figure 7(b)) transfected with the
wt RNA, a substantially diﬀerence in terms of productivity
clearly appears. In fact, the HCVcc titer reached in the
S6.1/E1E2:2a supernatant was approximately 10 fold higher
than that obtained from S6.1/E1E2:1b (Figure 7(a) versus
Figure 7(b)). If the hypothesis of genotypic incompatibility
is true, we might expect that E1E2 from genotype 1b could
compete with E1E2 from genotype 2a in interacting with
the other structural proteins from genotype 2a, thus leading
to an abortive assembly process. The lower viral titer with
respect to the one reached from S6.1/E1E2:2a cells would
thus be explained as displacement of genotype 2a E1E2 by
the glycoproteins expressed by S6.1/E1E2:1b. As evident in
Figure 7,thechimericgenomeJFH1/Con1E2showsthesame
behavior as the defective construct JFH1ΔE1E2, conﬁrming
that the swapping of the E2 ectodomain is equivalent to the
deletion of the E2 envelope protein coding region. Impor-
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Figure 7: Infectivity of transcomplemented JFH1ΔE1E2 and
JFH1/Con1E2 defective viral genomes. In vitro transcribedgenomic
JFH1ΔE1E2, Con1E2 defective RNAs and the full-length JFH1
genome were delivered to S6.1/E1E2:2a (a) and S6.1/E1E2:1b
(b) packaging cell lines that stably express E1 and E2 HCV
proteins of genotype 2a and 1b, respectively. From day 3 to day
7 after transfection, cell supernatants were collected and tested
for infectivity (pfu/ml) by serial dilution and immunoﬂuorescence
against core protein.
tantly, only in S6.1/E1E2:2a cell supernatants, we recovered
infectious particles upon transfection with both JFH1ΔE1E2
and JFH1/Con1E2 RNAs (Figure 7(a)). This clearly indicates
that the transcomplementation is possible, but only when
the packaging cell provides autologous envelope proteins.
Indeed, as evident by the absence of infectious particles in
the supernatant, S6.1/E1E2:1b cells are not able to rescue the
defective assembly function of neither JFH1ΔE1E2, nor of
the JFH1/Con1E2 genome (Figure 7(b)).
4. Discussion and Conclusion
The recent development of the full HCV infectious system
(HCVcc) by Wakita and colleagues for the JFH1 strain [5]
has represented a big breakthrough in HCV research since it12 International Journal of Hepatology
allows to study the complete life cycle of HCV and to deﬁne
therolesofproteinsthatarenotrequiredforviralRNArepli-
cation. Following this achievement, several eﬀorts have been
madetoextendthiscellculturesystemtoallHCVgenotypes,
but these attempts have ended with the conclusion that for
unknown reasons, the JFH1 backbone is absolutely required.
To overcome the restriction to JFH1 strain, chimeric viruses
of representative HCV strains belonging to genotypes 1 to
7[ 6] have been generated. Commonly reported chimeras
consist of the 3 -half of the JFH1 genome and the 5 -moiety
of the other strain, extending to p7 and part or whole
of NS2. However, while the construction of intragenotypic
chimera was highly successful, several reports pointed out
that the virus yield obtained using intergenotypic chimeras
was reduced and often required adaptive mutations for the
establishment of a cell culture system.
In the present study, we explored the possibility of
establishing a general procedure to obtain cell culture
chimeric infectious particles by strain-swapping the soluble
domain of the E1 and E2 envelope proteins. This strategy
would allow genotypic-speciﬁc studies of therapeutics that
target viral entry steps, such as neutralizing monoclonal
antibodies or fusion inhibitors and would provide useful
information on viral assembly determinants. The rationale
underlying our approach was the following: E1 and E2
soluble moieties are the only domains that face into the
ER-lumen and are thus exposed on the surface of mature
virions. The remaining HCV proteins are either anchored
to the cytoplasmic side of the ER membrane or, in the case
of core, are localized on the surface of lipid droplets. The
C-terminus region of NS2 is still a matter of debate since
its topology has not yet been determined. According to a
recent model of virus assembly proposed by Miyanary et
al. [32], all interactions necessary for the formation of the
nascent particles should involve the cytoplasmic oriented
domains or the TM regions. Since in our constructs all these
regions were conserved from the JFH1 strain, the swapping
of the envelope protein ectodomain should not interfere
with the assembly mechanism. From these considerations,
we have constructed and analyzed two novel intergenotypic
HCV chimeras, still based on the JFH1 strain backbone, with
only the ectodomain of the E1 and/or E2 envelope proteins
substituted with the analogous region taken from the Con1
strain (genotype 1b). Based on predictive computer analysis
and data from the literature, we extended the canonical TM
regionsinordertoguaranteetheexchangeofonlythesoluble
part of the E1 and E2 proteins, thus maintaining potential
membranotropic domains. The completely secreted forms
of E1 and E2 are truncated in their C-terminus at position
311 and 661, respectively, (or position 668 in strain 1a)
[42] although it has been claimed that E1 has an internal
TM that could allow the adoption of a polytopic form
[43, 44]. In any case, there is a general consensus that the
position of the TM region starts at position 352 and 715
for E1 and E2, respectively [45]. As a consequence, there is
a gap of 40–50 residues that is responsible for the partial
or complete retention of the two proteins into the ER even
if it is not inserted in the membrane. According to this
data, we swapped the unequivocally deﬁned ectodomain
portions (192–330 and 384–683, resp., for E1 and E2) and
maintained the TM and the pre-TM regions of JFH1 (i.e.,
312–330 and 669–683 for E1 and E2, resp.). For these JFH1
regions, the structure prediction of the N-terminus part is
compatiblewithanamphipathicα-helixlyingalmostparallel
with the membrane, establishing hydrophobic interactions
withthelipidbilayerandexposingupwardfacinghydrophilic
residues. Although this prediction has not been experimen-
tally conﬁrmed yet, the overall architecture of the TM and
pre-TM regions of E1E2 would be very similar to that
described for the ME complex of the Dengue Virus [46].
Analysis of the described chimeras, named JFH/
Con1E1E2 and JFH1/Con1E2, was performed in parallel
with the defective genome JFH1ΔE1E2 (without the E1 and
E2 coding sequence) and with JFH1 wt. As expected, the
E1 and E2 envelope proteins are not involved in the HCV
genome replication process, since both chimeric constructs,
aswellasthedefectivegenome,areabletoeﬃcientlyreplicate
in S6.1 hepatoma cells. This observation is in agreement
with the common role assigned to E1 and E2 proteins.
Indeed, their predominant function as components of the
viral spikes make them crucial for HCV entry into target cell,
but dispensable for RNA replication [47, 48]. Conversely, it
is quite surprising that none of the chimeric HCV genomes
allow the production of infectious viral particles and behave
like the ΔE1E2 defective RNA in this respect. Although it
was already observed that deletion of the two glycoproteins
from the viral genome impairs core secretion, which is an
index for viral particle production [5], here, we extend this
data and determined that even the heterodimer formation is
not suﬃcient for virus production. In the attempt to explain
this issue, we focused our attention on the JFH1/Con1E2
chimericconstruct,inwhichonlytheE2ectodomainportion
is swapped. It has recently been demonstrated that E1 can
associatewithcoreproteinthroughacytoplasmicloopofﬁve
amino acids that show a high variability between genotypes
2a and 1b [22]. By using the JFH1/Con1E2 construct,
we could exclude the possibility that the Con1-derived E1
protein is simply unable to interact with the capsid protein.
Moreover, this chimera allowed us to obtain more useful
information on the role of the E2 glycoprotein in HCV mor-
phogenesis. To rule out a nonfunctional interaction between
GT2a E1 and GT1b E2 glycoproteins, we ﬁrst analyzed the
foldingprocessoftheE1E2heterodimers.Inouranalysis,the
chimeric E1E2 complex reaches the same maturation as the
wt heterodimers, even though the pathway is slightly delayed
inproteinprecursorprocessing,oxidationkinetics,andE1E2
association. It is unlikely that a slower maturation process
could lead to a complete loss of functionality, and diﬀerent
kinetics have already been described as genotype-associated
in studies with recombinant proteins [7]. Therefore, the
presence of chimeric heterodimers prompted us to evaluate
subsequentstepsintheviralmorphogenesis,inparticularthe
assembly process.
Confocal microscopy analysis ﬁrstly suggested that
chimeric particle assembly is in some way aﬀected by the E2
ectodomain exchange. In fact, although core, E1E2 and NS5a
proteins mostly display the same subcellular localization
pattern in S6.1/JFH1 and S6.1/Con1E2 cells, we noted aInternational Journal of Hepatology 13
peripheral accumulation of lipid droplets (LDs) coated by
the capsid protein in almost all cells transfected with the
chimeric genome. LDs were recently discovered as the site of
HCV assembly[32],andtheirlocalizationisusuallyfoundas
perinuclear. The observed accumulation of core-coated LDs
attheperipheryoftheS6.1/Con1E2cellsappearstobeacon-
sequence of a defective assembly process and could indicate
a block in the secretion of competent, although immature,
particles. In fact, it has been described that the production of
extracellularinfectiousvirusisprecededbytheaccumulation
of intracellular immature infectious precursors that reach
their ﬁnal conﬁguration along their egress [36, 37]. These
particles are revealed as infectious species following cell
rupture by freeze-thaw treatments. As we did not detect
immature infectious precursor within S6.1/Con1E2 cells, we
can conclude that the role of E2 in particle assembly is
relevant early in morphogenesis. An additional observation
supporting the accumulation of nonfunctional structures is
the copresence of viral structural and nonstructural proteins
in dense pointed structures, noted as dots, in the chimeric
RNA-transfected cells. Presumably, these dots represent sites
inwhichtheviralproteinsarestoredinsteadofbeingreleased
as mature particles. It is worth mentioning that in the
replicon system the co-localization of viral structural and
nonstructural proteins in dot-like structures was commonly
detected [33]. In that context, it was suggested that dots
represent HCV prebudding areas where all the viral proteins
and RNA accumulate on ER-derived membranes. So far, our
results argue against this conclusion, since we did not detect
any similar co-localization of E1E2, core, and NS5a proteins
into virus-producing cells. Since the replicon system, as
well as S6.1/Con1E2 cells, did not allow the production
of infectious viral particles, we hypothesize that dots are
the result of an ineﬃcient assembly process rather then a
prebudding area.
The observation that in JFH1/Con1E2-cells infectious
particlesweresecretedfollowingtranscomplementationwith
the genotype 2a E2 protein further indicates that E2 acts in
a strain-speciﬁc context. For HCV, it is already known that
the entire structural region, from the core to the N-terminus
of NS2, can be transcomplemented [41] whilst all viral
proteins involved in RNA replication, with the exception
of NS5A, cannot be provided in trans [34]. Providing the
genotype 2a E2 (i.e., from the same isolate as the remaining
structural region), we were able to rescue the virus produc-
tion abolished by the E2 ectodomain exchange. The virus
titersreachedwiththeJFH1/Con1E2genomecomplemented
in trans are lower than that obtained with the JFH1 wt
RNA, but they are identical to those obtained following
trans complementation of ΔE1E2 defective genome. This
observationstronglyindicatesthattheinfectiousparticlesare
most likely decorated with the wild type E1E2 heterodimers
provided by the packaging cell. Unfortunately, the lacking
of genotype-speciﬁc anti-E2 antibodies did not allow us to
distinguish between wild type and chimeric HCV particles.
The swapping of the E2 ectodomain could abolish virus
production in two possible ways. The introduction of a
diﬀerent E2 domain, although taken from an infectious
strain, could alter the ﬁne balance of events that precedes
the assembly of viral particles by impairing the formation of
structures of a higher order than the heterodimer thus com-
pletely eliminating their infectious ability. Indeed, although
we have demonstrated that chimeric E1E2 can associate,
the sedimentation analysis of E2 complexes indicated an
abundance of heterogeneous species in the chimeric case.
Thus, it is possible that although E1E2 heterodimers can
achieve a certain degree of native conformation, they can
not progress to viral incorporation due to the lack of a fully
competent state. Another possibility is that E2 ectodomain
inﬂuencesthecellculture-producedHCVbyinteractingwith
one or more of the other viral proteins (e.g., core, p7 or
NS2) during the viral assembly process. This hypothesis is
in agreement with several lines of evidence. Firstly, all the
chimeric JFH1-based viruses successfully obtained contain
the entire genotype 2a structural region, from the core
to the NS2 protein [3, 4, 7], overcoming the potential
incompatibility among structural proteins (including p7
and NS2) derived from diﬀerent genotypes. Furthermore,
it is worth mentioning that a genotypic incompatibility has
already been observed for other HCV proteins, namely, p7
and NS2 [3, 4, 7, 49]. In particular, it was demonstrated that
both p7 and NS2 proteins are essential for infectious particle
assembly and release, and that their function most likely
implies genotypic-speciﬁc interactions with other structural
proteins. Pietschmann and coworkers also suggested that
an interaction between E2 and NS2 might be important in
HCV morphogenesis [7]. Our results are in line with this
observation and add the information that such interaction
requires a precise region of the E2 protein, namely, the
ectodomain portion. Alternatively, the genotype-speciﬁc
recognition of the E2 ectodomain could involve core or p7
proteins. We do not favor the latter possibility as the small
polypeptide p7 is embedded in the ER membrane, and thus
its interaction with the soluble portion of E2 is unlikely.
For the same reason, the interaction with core protein is
highly underprivileged since the E2 ectodomain is oriented
towards the ER-lumen, whilst the core protein resides in
the cytoplasm. Conversely, the relative positions of the E2
ectodomain and NS2 in the ER membrane argue for their
interaction. Although the precise topology of NS2 is not
yet deﬁned, one possibility is that its soluble portion is ER-
lumen exposed [50] and thus available for the interaction
with the envelope protein.
In conclusion, we demonstrated that the soluble region
of the HCV-E2 glycoprotein is essential for the production of
infectious particles in the HCVcc system and suggest that it
actsinconcertwiththeotherviralstructuralproteinsatearly
stage of viral assembly in a genotypic-speciﬁc way.
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